VYGR - Voyager Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.40
DETAILS
HIGH:
$18.00
LOW:
$8.00
MEDIAN:
$18.00
CONSENSUS:
$14.40
UPSIDE:
278.95%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 40.4 | 80.0 | 250.0 | 40.9 | 37.4 | 171.1 | 104.4 | 7.6 | 10.1 | 14.2 | 17.3 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 92.2 | 55.8 | 73.8 | 108.8 | 119.7 | 64.9 | 62.3 | 42.2 | 27.7 | 8.9 | 4.6 |
| Gross Profit | 40.4 | 80.0 | 157.8 | (14.9) | (36.4) | 62.4 | (15.3) | (57.3) | (52.1) | (28.0) | (10.3) | (8.9) | (4.6) |
| Operating Expenses | |||||||||||||
| R&D Expenses | 134.7 | 127.4 | 92.2 | 60.8 | 73.8 | 108.8 | 119.7 | 64.9 | 62.3 | 42.2 | 27.7 | 8.9 | 4.6 |
| SG&A Expenses | 37.5 | 35.9 | 35.8 | 31.0 | 37.2 | 35.0 | 36.3 | 33.8 | 19.7 | 13.3 | 9.9 | 5.5 | 2.9 |
| Other Expenses | 0 | 0 | (92.2) | (55.8) | (73.8) | (108.8) | (119.7) | 2.6 | 1.2 | 1.2 | (9.4) | 0 | 0 |
| Operating Expenses | 172.2 | 163.3 | 35.8 | 36.0 | 37.2 | 35.0 | 36.3 | 98.7 | 82.0 | 55.5 | 37.6 | 14.4 | 2.9 |
| Operating Income | |||||||||||||
| Operating Income | (131.8) | (83.3) | 122.0 | (50.8) | (73.6) | 27.4 | (51.7) | (91.1) | (71.9) | (41.3) | (20.3) | (14.4) | (7.5) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.0 | 0.3 | 0 | 0 |
| Interest Income | 10.6 | 18.3 | 11.7 | 1.8 | 0 | 1.7 | 6.5 | 3.3 | 1.2 | 0 | 0 | 0 | 0.1 |
| Profitability | |||||||||||||
| EBITDA | (127.8) | (78.6) | 126.5 | (39.6) | (68.5) | 31.2 | (48.9) | (89.0) | (70.3) | (40.7) | (19.7) | (14.2) | 0 |
| EBIT | (131.8) | (83.3) | 122.0 | (45.8) | (73.6) | 27.4 | (51.7) | (91.1) | (71.9) | (41.3) | (20.3) | (14.4) | (7.5) |
| Income Before Tax | (119.6) | (64.3) | 133.7 | (46.4) | (71.2) | 36.7 | (43.6) | (88.5) | (70.7) | (40.1) | (29.7) | (16.3) | (7.7) |
| Income Tax Expense | 0.1 | 0.7 | 1.4 | 0.0 | 0 | 0 | 0 | (0.2) | 0 | 0.1 | 0 | 0 | 0 |
| Net Income | (119.7) | (65.0) | 132.3 | (46.4) | (71.2) | 36.7 | (43.6) | (88.3) | (70.7) | (40.2) | (29.7) | (16.3) | (7.7) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -2.04 | -1.13 | 3.08 | -1.21 | -1.75 | 0.99 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| EPS (Diluted) | -2.04 | -1.13 | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| Shares Outstanding | 58.7 | 57.7 | 43.0 | 38.4 | 37.7 | 37.1 | 35.9 | 32.1 | 26.8 | 25.3 | 4.2 | 14.7 | 0.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 65.3 | 71.4 | 68.8 | 99.0 | 117.4 | 104.4 | 86.0 | 46.9 | 31.5 | 36.6 |
| Short-Term Investments | 131.1 | 195.3 | 162.1 | 19.9 | 15.1 | 76.7 | 195.5 | 108.9 | 137.5 | 137.8 |
| Net Receivables | 1.8 | 4.5 | 84.5 | 0.6 | 0.7 | 8.0 | 18.7 | 0.2 | 0 | 2.3 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 2.2 | 5.1 | 1.9 | 1.5 |
| Other Current Assets | 4.5 | 2.9 | 2.6 | 4.2 | 1.7 | 7.2 | 2.0 | 1.4 | 2.2 | 0.4 |
| Total Current Assets | 202.7 | 276.8 | 319.7 | 124.5 | 136.7 | 197.8 | 304.7 | 162.5 | 171.8 | 178.8 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 41.6 | 47.7 | 30.0 | 33.3 | 55.4 | 61.5 | 46.5 | 12.8 | 10.3 | 7.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 65.7 | 0 | 0 | 0 | 0 | 1.9 | 0.6 | 1.1 | 1.4 |
| Other Non-Current Assets | 8.0 | 2.9 | 1.6 | 1.5 | 1.8 | 2.3 | 1.7 | 1.1 | 1.3 | 1.5 |
| Total Non-Current Assets | 49.6 | 116.2 | 31.6 | 34.9 | 57.2 | 63.8 | 50.1 | 14.5 | 12.7 | 10.8 |
| Total Assets | 252.3 | 393.1 | 351.3 | 159.4 | 193.9 | 261.6 | 354.8 | 177.0 | 184.5 | 189.6 |
| Current Liabilities | ||||||||||
| Account Payables | 5.0 | 4.0 | 1.6 | 2.6 | 0.6 | 0.6 | 4.1 | 1.0 | 1.0 | 0.6 |
| Short-Term Debt | 7.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.6 | 24.4 | 42.9 | 59.4 | 33.9 | 0 | 47.2 | 20.8 | 3.4 | 6.8 |
| Other Current Liabilities | 12.1 | 6.8 | 6.6 | 4.6 | 5.0 | 7.7 | 15.8 | 6.0 | 8.1 | 4.1 |
| Total Current Liabilities | 26.5 | 49.8 | 64.5 | 72.6 | 51.0 | 26.8 | 76.0 | 31.7 | 15.9 | 13.8 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | (47.2) | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1 | 1 | 1 | 1.0 | 1.0 | 37.1 | 1.0 | 6.7 | 6.3 | 5.0 |
| Total Non-Current Liabilities | 29.7 | 43.5 | 50.5 | 27.7 | 47.8 | 80.5 | 179.2 | 98.9 | 34.5 | 39.8 |
| Total Liabilities | 56.2 | 93.3 | 115.0 | 100.3 | 98.8 | 107.3 | 255.2 | 130.6 | 50.4 | 53.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (445.9) | (326.2) | (261.2) | (393.5) | (347.1) | (275.9) | (312.6) | (269.1) | (160.7) | (90.0) |
| Accumulated Other Comprehensive Income | 0.0 | (0.4) | (0.0) | (0.2) | (0.1) | (0.1) | (0.1) | (0.1) | (0.3) | (0.1) |
| Total Stockholders' Equity | 196.1 | 299.8 | 236.3 | 59.0 | 95.1 | 154.3 | 99.5 | 46.4 | 134.1 | 135.9 |
| Total Liabilities & Equity | 252.3 | 393.1 | 351.3 | 159.4 | 193.9 | 261.6 | 354.8 | 177.0 | 184.5 | 189.6 |
| Debt Metrics | ||||||||||
| Total Debt | 36.5 | 43.7 | 20.3 | 23.1 | 44.2 | 47.6 | 34.2 | 0 | 0 | 0 |
| Net Debt | (28.8) | (27.6) | (48.5) | (75.8) | (73.3) | (56.8) | (51.9) | (46.9) | (31.5) | (36.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (119.7) | (65.0) | 132.3 | (46.4) | (71.2) | 36.7 | (43.6) | (88.3) | (70.7) | (40.2) |
| Depreciation & Amortization | 4.1 | 4.7 | 4.4 | 6.2 | 5.2 | 3.8 | 2.8 | 2.1 | 1.6 | 0.6 |
| Stock-Based Compensation | 14.8 | 14.8 | 11.2 | 9.3 | 11.3 | 14.9 | 15.6 | 15.7 | 9.2 | 6.3 |
| Change in Working Capital | (28.8) | 34.9 | (66.6) | 20.5 | 3.3 | (144.5) | 78.4 | 55.4 | (2.1) | (12.8) |
| Other Non-Cash Items | (2.8) | (4.7) | (3.4) | (2.1) | (2.1) | (7.7) | (4.6) | 1.4 | 0.7 | 2.9 |
| Operating Cash Flow | (132.5) | (15.3) | 77.9 | (12.5) | (53.5) | (96.7) | 48.7 | (15.9) | (61.4) | (42.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | (2.6) | (3.5) | (3.3) | (2.5) | (1.6) | (12.1) | (7.7) | (4.3) | (4.0) | (5.0) |
| Acquisitions | 0 | 0 | 138.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (133.9) | (465.7) | (224.0) | (54.8) | (15.1) | (70.4) | (494.2) | (333.2) | (147.3) | (112.3) |
| Sales/Maturities of Investments | 262.0 | 374.3 | 85.6 | 50 | 82.6 | 195.5 | 411.3 | 364 | 147.6 | 165.1 |
| Other Investing Activities | 0 | 0 | (138.4) | 0 | 0 | 0 | 0.2 | 30.8 | 0.3 | (0.4) |
| Investing Cash Flow | 125.4 | (94.9) | (141.6) | (7.3) | 65.9 | 113.0 | (90.5) | 26.5 | (3.7) | 47.3 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.9 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 | 3.2 | 3.4 | 4.7 | 1.9 | 0.5 |
| Financing Cash Flow | 0.8 | 114.0 | 33.6 | 1.1 | 0.6 | 3.2 | 81.0 | 4.7 | 59.9 | 0.5 |
| Cash Position | ||||||||||
| Net Change in Cash | (6.2) | 3.8 | (30.1) | (18.5) | 13.0 | 18.4 | 39.2 | 15.3 | (5.1) | 5.3 |
| Cash at Beginning | 74.2 | 70.4 | 100.5 | 117.4 | 104.4 | 86.0 | 47.6 | 32.3 | 36.6 | 31.3 |
| Cash at End | 68.0 | 74.2 | 70.4 | 99.0 | 117.4 | 104.4 | 86.8 | 47.6 | 31.5 | 36.6 |
| Free Cash Flow | (135.1) | (18.8) | 74.7 | (15) | (55.1) | (108.8) | 40.9 | (20.2) | (65.3) | (47.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 40.4 | 80.0 | 250.0 | 40.9 | 37.4 | 171.1 | 104.4 | 7.6 | 10.1 | 14.2 | 17.3 | 0 | 0 |
| Gross Profit | 40.4 | 80.0 | 157.8 | (14.9) | (36.4) | 62.4 | (15.3) | (57.3) | (52.1) | (28.0) | (10.3) | (8.9) | (4.6) |
| Operating Income | (131.8) | (83.3) | 122.0 | (50.8) | (73.6) | 27.4 | (51.7) | (91.1) | (71.9) | (41.3) | (20.3) | (14.4) | (7.5) |
| Net Income | (119.7) | (65.0) | 132.3 | (46.4) | (71.2) | 36.7 | (43.6) | (88.3) | (70.7) | (40.2) | (29.7) | (16.3) | (7.7) |
| EPS (Diluted) | -2.04 | -1.13 | 2.97 | -1.21 | -1.75 | 0.98 | -1.14 | -2.75 | -2.64 | -1.59 | -7.08 | -1.11 | -16.55 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 65.3 | 71.4 | 68.8 | 99.0 | 117.4 | 104.4 | 86.0 | 46.9 | 31.5 | 36.6 | |||
| Total Assets | 252.3 | 393.1 | 351.3 | 159.4 | 193.9 | 261.6 | 354.8 | 177.0 | 184.5 | 189.6 | |||
| Total Debt | 36.5 | 43.7 | 20.3 | 23.1 | 44.2 | 47.6 | 34.2 | 0 | 0 | 0 | |||
| Stockholders' Equity | 196.1 | 299.8 | 236.3 | 59.0 | 95.1 | 154.3 | 99.5 | 46.4 | 134.1 | 135.9 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (132.5) | (15.3) | 77.9 | (12.5) | (53.5) | (96.7) | 48.7 | (15.9) | (61.4) | (42.5) | |||
| Capital Expenditure | (2.6) | (3.5) | (3.3) | (2.5) | (1.6) | (12.1) | (7.7) | (4.3) | (4.0) | (5.0) | |||
| Free Cash Flow | (135.1) | (18.8) | 74.7 | (15) | (55.1) | (108.8) | 40.9 | (20.2) | (65.3) | (47.5) | |||